| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BTTX | Better Therapeutics, Inc. | KARBE FRANK | Chief Executive Officer | Jul 27, 2023 | Buy | $0.73 | 137,005 | 100,000 | 429,429 | Jul 31, 2023, 07:58 AM | |
| BTTX | Better Therapeutics, Inc. | KARBE FRANK | See Remarks | Apr 10, 2023 | Buy | $0.82 | 242,424 | 200,000 | 292,424 | Apr 12, 2023, 04:15 PM | |
| BTTX | Better Therapeutics, Inc. | KARBE FRANK | See Remarks | Sep 15, 2022 | Buy | $2.09 | 50,000 | 104,695 | 50,000 | Sep 15, 2022, 08:53 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Jul 07, 2021 | Sale | $21.75 | 3,232 | 70,296 | 212,296 | Jul 09, 2021, 04:27 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Apr 06, 2021 | Sale | $18.63 | 11,080 | 206,420 | 152,390 | Apr 08, 2021, 04:55 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Feb 16, 2021 | Option Exercise | $13.25 | 1,500 | 19,882 | 164,220 | Feb 18, 2021, 04:52 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Jan 28, 2021 | Option Exercise | $14.56 | 600 | 8,733 | 163,770 | Feb 01, 2021, 04:29 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Jan 15, 2021 | Option Exercise | $13.31 | 1,500 | 19,958 | 164,220 | Jan 20, 2021, 04:39 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Dec 28, 2020 | Option Exercise | $17.56 | 23,600 | 414,298 | 175,270 | Dec 30, 2020, 04:29 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Dec 15, 2020 | Sale | $14.63 | 2,100 | 30,728 | 164,520 | Dec 17, 2020, 04:51 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Nov 30, 2020 | Option Exercise | $14.56 | 3,000 | 43,665 | 164,970 | Dec 02, 2020, 05:08 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Nov 17, 2020 | Option Exercise | $12.56 | 1,500 | 18,833 | 164,220 | Nov 19, 2020, 05:04 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Nov 13, 2020 | Option Exercise | $12.56 | 1,500 | 18,833 | 164,220 | Nov 17, 2020, 06:50 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Sep 15, 2020 | Option Exercise | $13.42 | 1,500 | 20,130 | 164,220 | Sep 17, 2020, 04:20 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Aug 28, 2020 | Option Exercise | $12.58 | 7,300 | 91,798 | 167,120 | Sep 01, 2020, 04:37 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Aug 31, 2020 | Option Exercise | $12.56 | 42,300 | 531,351 | 184,620 | Sep 01, 2020, 04:37 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Aug 19, 2020 | Option Exercise | $12.56 | 1,400 | 17,577 | 164,170 | Aug 21, 2020, 05:07 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Dec 30, 2019 | Sale | $15.55 | 19,701 | 306,351 | 43,324 | Dec 30, 2019, 07:13 PM | |
| MYOV | Myovant Sciences Ltd. | KARBE FRANK | Principal Fin'l & Accounting | Jun 11, 2019 | Buy | $9.10 | 8,000 | 72,800 | 8,000 | Jun 11, 2019, 04:55 PM | |
| EXEL | EXELIXIS INC | KARBE FRANK | EVP & CFO | Aug 24, 2010 | Buy | $2.98 | 16,500 | 49,165 | 60,110 | Aug 25, 2010, 08:51 PM |
Menu